Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 15;14(6):1199-1209.
doi: 10.4251/wjgo.v14.i6.1199.

Does chronic kidney disease affect the complications and prognosis of patients after primary colorectal cancer surgery?

Xiao-Yu Liu  1 , Bin Zhang  1 , Yu-Xi Cheng  1 , Wei Tao  1 , Chao Yuan  1 , Zheng-Qiang Wei  1 , Dong Peng  2
Affiliations

Does chronic kidney disease affect the complications and prognosis of patients after primary colorectal cancer surgery?

Xiao-Yu Liu et al. World J Gastrointest Oncol. .

Abstract

Background: The effect of chronic kidney disease (CKD) on the outcomes of colorectal cancer (CRC) patients after primary CRC surgery is controversial.

Aim: To analyze whether CKD had specific effect on the outcomes after CRC surgery.

Methods: We searched the PubMed, Embase, Cochrane Library databases and CNKI, from inception to March 14, 2022. Newcastle-Ottawa Scale was used for the quality assessment in this meta-analysis, and we used RevMan 5.3 was used for data analysis.

Results: A total of nine studies including 47771 patients were eligible for this meta-analysis. No significant difference was found in terms of overall postoperative complications [odds ratio (OR) = 1.78, 95%CI: 0.64-4.94, P = 0.27]. We analyzed the specific complications and found that the CKD group had higher rates of pulmonary infection (OR = 2.70, 95%CI: 1.82-4.00, P < 0.01), cardiovascular complications (OR = 3.39, 95%CI: 2.34-4.91, P < 0.01) and short-term death (OR = 3.01, 95%CI: 2.20-4.11, P < 0.01). After pooling the hazard ratio (HR), the CKD group had worse overall survival (OS) (HR = 1.51, 95%CI: 1.04-2.20, P = 0.03). We performed subgroup analyses of the dialysis and non-dialysis groups, and no significant difference was found in the non-dialysis group (HR = 1.20, 95%CI: 0.98-1.47, P = 0.08). The dialysis group had worse OS (HR = 3.36, 95%CI: 1.92-5.50, P < 0.01) than the non-dialysis group. The CKD group had worse disease-free survival (DFS) (HR = 1.41, 95%CI: 1.12-1.78, P < 0.01), and in the subgroup analysis of the dialysis and non-dialysis groups, no significant difference was found in the non-dialysis group (HR = 1.27, 95%CI: 0.97-1.66, P = 0.08). The dialysis group had worse OS (HR = 1.95, 95%CI: 1.23-3.10, P < 0.01) than the non-dialysis group.

Conclusion: Preexisting CKD was associated with higher rates of pulmonary infection, higher rates of short-term death, and worse OS and poorer DFS following CRC surgery.

Keywords: Chronic kidney disease; Colorectal cancer; Meta-analysis; Outcome; Prognosis.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Flowchart of study selection.
Figure 2
Figure 2
Complications. A: Overall complications between the chronic kidney disease (CKD) group and the non-CKD group; B: Subgroup analysis of the non-dialysis groups; C: Subgroup analysis of the dialysis groups.
Figure 3
Figure 3
Overall survival. A: Overall survival between the chronic kidney disease (CKD) group and the non-CKD group; B: Subgroup analysis of the non-dialysis groups; C: Subgroup analysis of the dialysis groups.
Figure 4
Figure 4
Disease-free survival. A: Disease-free survival between the chronic kidney disease (CKD) group and the non-CKD group; B: Subgroup analysis of the non-dialysis groups; C: Subgroup analysis of the dialysis groups.
See this image and copyright information in PMC

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
    1. Ergun Y, Bal O, Dogan M, Ucar G, Dirikoc M, Acikgoz Y, Bacaksiz F, Uncu D. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer? J Res Med Sci. 2020;25:14. - PMC - PubMed
    1. Bundred NJ. Erratum to "Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK" [Eur J Surg Oncol 43 (5) (2017) 931-937] Eur J Surg Oncol. 2018;44:194. - PubMed
    1. Peng D, Cheng YX, Cheng Y. Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta-Analysis. Biomed Res Int. 2021;2021:5541613. - PMC - PubMed
    1. Feliu J, Espinosa E, Basterretxea L, Paredero I, Llabrés E, Jiménez-Munárriz B, Antonio-Rebollo M, Losada B, Pinto A, Custodio AB, Del Mar Muñoz M, Gómez-Mediavilla J, Torregrosa MD, Soler G, Cruz P, Higuera O, Molina-Garrido MJ. Prediction of Chemotoxicity, Unplanned Hospitalizations and Early Death in Older Patients with Colorectal Cancer Treated with Chemotherapy. Cancers (Basel) 2021;14:127. - PMC - PubMed